Sec Form 3 Filing - Guerrica Jennifer @ Health In Tech, Inc. - 2025-03-17

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Guerrica Jennifer 2. Issuer Name and Ticker or Trading Symbol Health In Tech, Inc. [ HIT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CISO (Last) (First) (Middle) 701 S. COLORADO AVE, SUITE 1 3. Date of Earliest Transaction (MM/DD/YY) 03/17/2025 (Street) STUART, FL34994 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 7,500 D Class A Common Stock 15,000 ( 1 ) D Class A Common Stock 6,000 ( 2 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exerci sable Expiration Date Title Amount or Number of Shares Stock Options $ 0.71 ( 3 ) 07/01/2028 Class A Common Stock 15,000 D Stock Options $ 0.71 ( 4 ) 07/01/2028 Class A Common Stock 12,000 D Stock Options $ 0.71 ( 5 ) 07/01/2028 Class A Common Stock 12,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Guerrica Jennifer 701 S. COLORADO AVE SUITE 1 STUART, FL34994 CISO Signatures /s/ Jennifer Guerrica 04/02/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest six months after the closing of the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date. ( 2 )Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest over three years, with one-third vesting upon the issuer's initial public offering, or December 24, 2024, and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date. ( 3 )Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest six months after the issuer's initial public offering, or June 24, 2025, subject to the reporting person's continued service with the issuer through such vesting date. ( 4 )Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vest over three years, with one-third of the options vesting upon the issuer's initial public offering, or December 24, 2024, and the remaining two-thirds vesting in equal quarterly installments over the remaining two years, subject to the reporting person's continued service with the issuer through each vesting date. ( 5 )Represent options to purchase shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan. The stock options vested upon the closing of the issuer's initial public offering, or December 24, 2024.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.